Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection

Virology

Volumn 327, Issue 2, 2004, Pages 242-248

  Burioni, Roberto ^a   Mancini, Nicasio ^a,b   Carletti, Silvia ^b   Perotti, Mario ^b   Grieco, Antonella ^a   Canducci, Filippo ^b   Varaldo, Pietro E ^a   Clementi, Massimo ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Anti HCV humoral response; Hepatitis C virus; Persistent infection; Quantitation of antibody subpopulations

Indexed keywords

ANTIBODY; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; CONFORMATION; CROSS REACTION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS ISOLATION;

ANTIBODIES, MONOCLONAL; CROSS REACTIONS; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 4544331326     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.042     Document Type: Article

References (26)

1. H.J. Alter, R.H. Purcell, J.W. Shih, J.C. Melpolder, M. Houghton, Q.L. Choo, and G. Kuo Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis N. Engl. J. Med. 321 22 1989 1494 1500
2. M.J. Alter, H.S. Margolis, K. Krawczynski, F.N. Judson, A. Mares, W.J. Alexander, P.Y. Hu, J.K. Miller, M.A. Gerber, and R.E. Sampliner The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team N. Engl. J. Med. 327 27 1992 1899 1905
3. C.F.d. Barbas, A.S. Kang, R.A. Lerner, and S.J. Benkovic Assembly of combinatorial antibody libraries on phage surfaces: the gene III site Proc. Natl. Acad. Sci. U.S.A. 88 18 1991 7978 7982
4. C.F.d. Barbas, E. Bjorling, F. Chiodi, N. Dunlop, D. Cababa, T.M. Jones, S.L. Zebedee, M.A. Persson, P.L. Nara, and E. Norrby Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro Proc. Natl. Acad. Sci. U.S.A. 89 19 1992 9339 9343
5. K. Bjoro, S.S. Froland, Z. Yun, H.H. Samdal, and T. Haaland Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin N. Engl. J. Med. 331 24 1994 1607 1611
6. F. Bugli, N. Mancini, C.Y. Kang, C. DiCampli, A. Grieco, A. Manzin, A. Gabrielli, A. Gasbarrini, G. Fadda, P.E. Varaldo, M. Clementi, and R. Burioni Mapping B cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries J. Virol. 75 20 2001 9986 9990
7. R. Burioni, P. Plaisant, F. Bugli, V. Delli Carri, M. Clementi, and G. Fadda A vector for the expression of recombinant monoclonal Fab fragments in bacteria J. Immunol. Methods 217 1â€"2 1998 195 199
8. R. Burioni, P. Plaisant, F. Bugli, L. Solforosi, V.D. Carri, P.E. Varaldo, and G. Fadda A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries Res. Virol. 149 5 1998 327 330
9. R. Burioni, P. Plaisant, A. Manzin, D. Rosa, V. Delli Carri, F. Bugli, L. Solforosi, S. Abrignani, P.E. Varaldo, G. Fadda, and M. Clementi Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments Hepatology 28 3 1998 810 814
10. R. Burioni, F. Bugli, N. Mancini, and G. Fadda A novel expression vector for production of epitope-tagged recombinant Fab fragments in bacteria Hum. Antibodies 10 3,4 2001 149 154
11. R. Burioni, F. Bugli, N. Mancini, D. Rosa, C. DiCampli, G. Moroncini, A. Manzin, S. Abrignani, P.E. Varaldo, M. Clementi, and G. Fadda Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs Virology 288 2001 29 35
12. R. Burioni, Y. Matsuura, N. Mancini, H. Tani, T. Miyamura, P.E. Varaldo, and M. Clementi Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype J. Virol. 76 22 2002 11775 11779
13. D.R. Burton, J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, P.W. Parren, L.S. Sawyer, R.M. Hendry, N. Dunlop, P.L. Nara, M. Lamacchia, E. Garratty, E.R. Stiehm, J.Y. Bryson, Y. Cao, J.P. Moore, D.D. Ho, and C.F. Barbas Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody Science 266 5187 1994 1024 1027
14. A. Cerny, and F.V. Chisari Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence Hepatology 30 3 1999 595 601
15. P. Farci, H.J. Alter, S. Govindarajan, D.C. Wong, R. Engle, R.R. Lesniewski, I.K. Mushahwar, S.M. Desai, R.H. Miller, and N. Ogata Lack of protective immunity against reinfection with hepatitis C virus Science 258 5079 1992 135 140
16. P. Farci, H.J. Alter, D.C. Wong, R.H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R.H. Purcell Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization Proc. Natl. Acad. Sci. U.S.A. 91 16 1994 7792 7796
17. T.P. Hopp, K.S. Prickett, V.L. Price, R.T. Libby, C.J. March, D.P. Cervetti, D.L. Urdal, and P.J. Corbon A short polypeptide marker sequence useful for recombinant protein identification and purification Bio/Technology 6 1988 1204 1210
18. M.E. Lai, A.P. Mazzoleni, F. Argiolu, S. De Virgilis, A. Balestrieri, R.H. Purcell, A. Cao, and P. Farci Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children Lancet 343 8894 1994 388 390
19. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N. Engl. J. Med. 345 1 2001 41 52
20. R. Lesniewski, G. Okasinski, R. Carrick, C. Van Sant, S. Desai, R. Johnson, J. Scheffel, B. Moore, and I. Mushahwar Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia J. Med. Virol. 45 4 1995 415 422
21. A. Manzin, L. Solforosi, M. Debiaggi, F. Zara, E. Tanzi, L. Romano, A.R. Zanetti, and M. Clementi Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection J. Virol. 74 9 2000 4327 4334
22. N. Ogata, H.J. Alter, R.H. Miller, and R.H. Purcell Nucleotide sequence and mutation rate of the H strain of hepatitis C virus Proc. Natl. Acad. Sci. U.S.A. 88 8 1991 3392 3396
23. M. Piazza, L. Sagliocca, G. Tosone, V. Guadagnino, M.A. Stazi, R. Orlando, G. Borgia, D. Rosa, S. Abrignani, F. Palumbo, A. Manzin, and M. Clementi Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial Arch. Intern. Med. 157 14 1997 1537 1544
24. P. Plaisant, R. Burioni, A. Manzin, L. Solforosi, M. Candela, A. Gabrielli, G. Fadda, and M. Clementi Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors Res. Virol. 148 2 1997 165 169
25. R.A. Williamson, R. Burioni, P.P. Sanna, L.J. Partridge, C.F.d. Barbas, and D.R. Burton Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries Proc. Natl. Acad. Sci. U.S.A. 90 9 1993 4141 4145
26. A. Zibert, E. Schreier, and M. Roggendorf Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment Virology 208 2 1995 653 661